Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In this study, we defined the role of peroxisome proliferator-activated receptor β/δ (PPARδ) in metabolic homeostasis by using subtype selective agonists. Analysis of rat L6 myotubes treated with the PPARδ subtype-selective agonist, GW501516, by the Affymetrix oligonucleotide microarrays revealed that PPARδ controls fatty acid oxidation by regulating genes involved in fatty acid transport, β-oxidation, and mitochondrial respiration. Similar PPARδ-mediated gene activation was observed in the skeletal muscle of GW501516-treated mice. Accordingly, GW501516 treatment induced fatty acid β-oxidation in L6 myotubes as well as in mouse skeletal muscles. Administration of GW501516 to mice fed a high-fat diet ameliorated diet-induced obesity and insulin resistance, an effect accompanied by enhanced metabolic rate and fatty acid β-oxidation, proliferation of mitochondria, and a marked reduction of lipid droplets in skeletal muscles. Despite a modest body weight change relative to vehicle-treated mice, GW501516 treatment also markedly improved diabetes as revealed by the decrease in plasma glucose and blood insulin levels in genetically obese ob / ob mice. These data suggest that PPARδ is pivotal to control the program for fatty acid oxidation in the skeletal muscle, thereby ameliorating obesity and insulin resistance through its activation in obese animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, SIRT1 activators like resveratrol and NAD+ precursors have been shown to enhance mitochondrial biogenesis and oxidative metabolism, leading to improved muscle function and recovery”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, PPAR agonists, such as pioglitazone (PPAR-γ) and the investigational GW501516 (PPAR-δ), have been shown in clinical and preclinical studies to enhance lipid metabolism and insulin sensitivity”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Treating mice with PPARα or PPARβ/δ agonists also induces, either directly or indirectly, an increase in whole body oxygen consumption without affecting caloric intake, thus accounting for lower rates of weight gain in response to high fat feeding (Guerre-Millo et al., 2000; Tanaka et al., 2003).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Tanaka et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
Research works printed but not linked: 1
- Dressel, U., Allen, T. L., Pippal, J. B., Rohde, P. R., Lau, P. & Muscat, G. E. (2003) Mol Endocrinol., in press. [DOI] [PubMed]
Cited by
Items 801–860 of 860
Docosahexaenoic Acid-Mediated Cytotoxicity in Immortalized Cells
Zlobine, I. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r36t00
Baker, L. A., Martin, N. R. W., Player, D. J., & Lewis, M. P. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/605949
Pan, H.-C., Yang, C.-N., Lee, W., Sheehan, J. P., Wu, S., Chen, H.-S., Lin, M.-H., Shen, L., Lee, S.-H., Shen, C.-C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1152032/v1
Fatty Acid Metabolism during Exercise
Katafuchi, T., & Makishima, M. (2021) · Journal of Nihon University Medical Association · doi:10.4264/numa.80.1_15
Boucher, P., & Vogel, H. G. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_53
Molecular Basis of Liver Disease
Monga, S. P., & Behari, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00020-1
Mandal, S., Muzaffar-Ur-Rehman, M., Puri, S., Kumar, B. K., Sharma, P. K., Murugesan, S., & Deepa, P. R. (2023) · Research Square · doi:10.21203/rs.3.rs-3137556/v1
Alessi, D. S., McCreery, C. V., & Zomorrodi, A. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.04.602078
Gemmink, A., van de Weijer, T., Schaart, G., Grabner, G. F., Moonen‐Kornips, E., Knoops, K., Zechner, R., Schweiger, M., & Hesselink, M. K. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.31.621255
Mitogenesis, mitophagy and regulation of mitochondrial metabolism in health and disease
Ward, C. G. (2025) · The Ukrainian Biochemical Journal · doi:10.15407/ubj97.04.005
Yang, C., Lv, M., Li, Y., He, Y., Zhang, S., Zhang, G., Lan, J., Guo, Z., Cheng, Y., Yang, Y., et al. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100498
Bojic, L. A. (2013) · Scholarship@Western (Western University)
Coleman, J. L., Carrigan, C. T., & Margolis, L. M. (2021) · Figshare · doi:10.6084/m9.figshare.14738456
Coleman, J. L., Carrigan, C. T., & Margolis, L. M. (2021) · Figshare · doi:10.6084/m9.figshare.14738459
Li, X., Zhou, T., Wu, Y., Sun, J., Wang, Z., Huang, Y., Xu, K., Ling, H., Li, N., Yang, T., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116416
Intestinal and skin homeostasis : targeting inflammation and cancer
El‐Jamal, N. (2012) · theses.fr (ABES) · doi:10.70675/19534eecz98c4z48b2z92f6z0eb4d568fe93
Étude du rôle de la production hépatique de glucose dans le développement du diabète et de l’obésité
Abdul-Wahed, A. (2012) · theses.fr (ABES) · doi:10.70675/61924053za287z4f04zb650zc51c1916ee64
Etude de la dysfonction cellulaire et moléculaire du syndrome mitochondrial MELAS.
Geffroy, G. (2017) · theses.fr (ABES) · doi:10.70675/a2ae3815zb7a8z4cbcz9a2dz22dbcd055adb
La nécroptose : une nouvelle cible thérapeutique dans la stéatohépatite non-alcoolique
Majdi, A. (2020) · theses.fr (ABES) · doi:10.70675/94f28bbaz6c2dz4b48zb1aaze6b48ca72708
Pterostilbene suppresses intracellular lipid accumulation in C2C12 myocytes via PPARδ stabilization
Suzuki, M., Iwasaki, M., Higashimura, Y., Takaya, T., & Mitani, T. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109519
SP, M. T. M., Habib, M. R., Tokutake, Y., & Yonekura, S. (2026) · Animal Science Journal · doi:10.1111/asj.70221
Shiino, S., Pascale, C. L., Motazedian, K., Lesser, E., Dumont, A., & Martinez, A. N. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02576-z
BindingDB Entry 50017904: 3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists: Part 1.
BindingDB (2009) · UC San Diego · doi:10.7270/q2v987pc
Ferroptosis Regulates Metabolic Inflammation–Driven Tumorigenesis in Obesity-Related Gastric Cancer
Tanabe, M., Uno, K., Tamahara, T., Asano, N., Koshiba, S., Kusano, K., Ogasawara, K., Kaise, Y., Saito, M., Koike, T., et al. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101900
Ikhlas, S., Alsharidah, A. R., Alkhodier, R. A., Senar, S., & Boudjelal, M. (2026) · Cancers · doi:10.3390/cancers18193231
Liu, X., Liu, C., Liu, G., Gao, S., Bai, L., Yang, Z., Zhang, D., & Sun, H. (2026) · Animals · doi:10.3390/ani16203162
Argano, C., Maggio, D., Pollicino, C., Cangialosi, V., Manno, S. B., Orlando, V., Monti, M. L., Grutta, A., Torres, A., & Corrao, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1784959
BindingDB (2012) · UC San Diego · doi:10.7270/q2k64jfx
BindingDB (2011) · UC San Diego · doi:10.7270/q2dz08nt
BindingDB Entry 3155: 3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists. Part 2.
BindingDB (2009) · UC San Diego · doi:10.7270/q23x84z3
BindingDB Entry 50014889: A Photohormone for Light-Dependent Control of PPARα in Live Cells.
BindingDB (2023) · UC San Diego · doi:10.7270/q2n87fnt
BindingDB Entry 50019918: Design of potent PPARalpha agonists.
BindingDB (2009) · UC San Diego · doi:10.7270/q2154gqc
BindingDB Entry 50017618: 1,3,5-Trisubstituted aryls as highly selective PPARdelta agonists.
BindingDB (2009) · UC San Diego · doi:10.7270/q2xw4jdg
BindingDB Entry 50018854: Design and synthesis of a novel class of dual PPARgamma/delta agonists.
BindingDB (2009) · UC San Diego · doi:10.7270/q2bp02f8
BindingDB Entry 50038030: Design of a partial PPARdelta agonist.
BindingDB (2012) · UC San Diego · doi:10.7270/q2mp5430
BindingDB Entry 50028418: Selective, potent PPARgamma agonists with cyclopentenone core structure.
BindingDB (2010) · UC San Diego · doi:10.7270/q2k35thg
BindingDB (2021) · UC San Diego · doi:10.7270/q2dj5jxg
BindingDB Entry 50000120: Polypharmacology of N
BindingDB (2019) · UC San Diego · doi:10.7270/q2xk8hqh
BindingDB (2009) · UC San Diego · doi:10.7270/q2nk3cc0
Efecte de l'activació de PPARβ/δ sobre l'oxidació d'àcids grassos i el procés inflamatori
Barroso, E. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Regulation of Mitochondrial Fuel Handling by the Peroxisome Proliferator-Activated Receptors
Sugden, M. C., & Holness, M. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-69945-5_3
(1998) · PubMed · Cited by 2,737
Metadata
- Authors
- Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., Watanabe, Y., Uchiyama, Y., Sumi, K., Iguchi, H., Ito, S., Doi, T., Hamakubo, T., Naito, M., Auwerx, J., Yanagisawa, M., Kodama, T., & Sakai, J.
- Affiliations
- Tohoku University (JP)
- Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo 153-8904, Japan; Pharmacology II, Department of Research and Development, Grelan Pharmaceutical Co. Ltd., Tokyo 205-8501, Japan; Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan; Yanagisawa Orphan Receptor Project, Exploratory Research for Advanced Technology, Japan...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-12-15
- Volume
- 100
- Issue
- 26
- Pages
- 15924-15929
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC307669
- OpenAlex
- W1982027543
- Cited by
- 832
- References
- 18
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 16 · 2023: 16 · 2022: 21 · 2021: 32 · 2020: 36 · 2019: 13 · 2018: 42 · 2017: 28 · 2016: 25 · 2015: 33 · 2014: 36 · 2013: 35 · 2012: 39
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- PPARδ, fatty acid beta-oxidation, skeletal muscle, metabolic syndrome, GW501516, insulin resistance, obesity, high-fat diet, mitochondrial respiration, fatty acid uptake, lipid droplets, diabetes mellitus, ob/ob mice, metabolic rate
- MeSH terms
- Animals, Dimethyl Sulfoxide, Enzymes, Fatty Acids, Nonesterified, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Oxidation-Reduction, Thiazoles, Transcription Factors, Receptors, Cytoplasmic and Nuclear, Muscle, Skeletal, Metabolic Syndrome, Lipid Metabolism, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.